NewLeaf Symbiotics, a company commercializing plant health and nutrient technologies that utilize naturally occurring beneficial bacteria, announced today the appointment of Sarita Chauhan Ph.D., MBA, as the Director of Fermentation and Technology Development. Chauhan joins the company from Decision Alternatives, an agricultural biotechnology consulting company she founded in 2011. She will work at NewLeaf’s St. Louis facility in the Bio Research & Development Growth (BRDG) Park at the Danforth Plant Science Center.
“Sarita brings extensive technical and managerial expertise to NewLeaf Symbiotics,” said Desmond Jimenez, NewLeaf’s Vice President of Product Development and Manufacturing. “She has a breadth of experience in the agrochemical industry including microbial genetics and biochemistry, metabolic engineering, bioinformatics, synthetic biology, bio-transformation, and bioprocess development.”
Dr. Chauhan brings 25 years of academic and industrial experience to NewLeaf, including 12 years at DuPont and 5 years on the entrepreneurial side as a Director at Algenol Biofuels and Coskata. “We are rapidly advancing our Prescriptive Biologics™ platform and product pipeline. Sarita is a welcome complement to the team and will accelerate our progress,” stated Jimenez.
Dr. Chauhan commented,“I am thrilled to join the growing team at NewLeaf. I believe that NewLeaf’s PPFM technology is likely to have the same impact for plant health and crop efficiency as probiotics have on human health.” Chauhan will be leading the effort to develop and scale-up bioprocesses for NewLeaf’s signature PPFM products.
About NewLeaf Symbiotics: NewLeaf Symbiotics is a non-GMO biotech company that researches and commercializes beneficial plant bacteria, and is a leading player in the rapidly growing agricultural biologicals space. In 2013 NewLeaf acquired bioinformatics solutions leader Intuitive Genomics, and employs a focused genomics approach to discovery and analysis of plant/microbe interactions. In Q-3, 2014, the company raised its Series B financing of $17M and has recently tripled its R&D footprint at BRDG Park in St Louis, Missouri. NewLeaf is expanding its team to 25 and expects initial product sales in 2016.
About BRDG Park at the Danforth Center (BRDG)
Bio Research & Development Growth (brdg-park.com) Park at the Danforth Plant Science Center helps life science companies bridge research, resources and relationships to achieve commercial success. In addition to providing world-class wet laboratories, office space and a prominent incubator, BRDG Park’s location on the Danforth Center’s campus facilitates access to the intellectual capital of top scientists, as well as to greenhouses, growth chambers, microscopy and proteomics facilities and other vital resources. Located in suburban St. Louis County, Missouri, BRDG Park is being developed by Wexford Science +Technology LLC, a BioMed Realty Company, a development company led by a seasoned team of real estate, finance and engineering experts specializing in major university facilities and science research parks nationwide.